Aegis Wealth Management LLC Purchases New Holdings in Johnson & Johnson (NYSE:JNJ)

Aegis Wealth Management LLC bought a new position in Johnson & Johnson (NYSE:JNJ - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 3,386 shares of the company's stock, valued at approximately $490,000.

Several other large investors have also added to or reduced their stakes in JNJ. Wood Tarver Financial Group LLC purchased a new position in Johnson & Johnson during the fourth quarter worth about $174,000. TFR Capital LLC. purchased a new position in shares of Johnson & Johnson in the 4th quarter worth approximately $313,000. Copley Financial Group Inc. grew its holdings in shares of Johnson & Johnson by 3.5% in the fourth quarter. Copley Financial Group Inc. now owns 4,320 shares of the company's stock valued at $625,000 after acquiring an additional 146 shares in the last quarter. Dogwood Wealth Management LLC lifted its holdings in Johnson & Johnson by 13.9% during the fourth quarter. Dogwood Wealth Management LLC now owns 4,224 shares of the company's stock worth $611,000 after acquiring an additional 514 shares during the period. Finally, American Investment Services Inc. purchased a new position in Johnson & Johnson in the fourth quarter worth $1,462,000. Institutional investors own 69.55% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the company. Morgan Stanley lifted their target price on Johnson & Johnson from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research note on Wednesday, April 16th. Barclays decreased their price target on shares of Johnson & Johnson from $166.00 to $165.00 and set an "equal weight" rating for the company in a research note on Thursday, April 17th. Sanford C. Bernstein reissued a "market perform" rating on shares of Johnson & Johnson in a report on Wednesday, April 16th. Leerink Partnrs lowered Johnson & Johnson from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, May 13th. Finally, Wall Street Zen downgraded Johnson & Johnson from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 22nd. Eleven investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, Johnson & Johnson currently has a consensus rating of "Moderate Buy" and a consensus price target of $170.88.

Johnson & Johnson Price Performance

Johnson & Johnson stock traded up $1.01 during mid-day trading on Thursday, hitting $153.44. 6,810,517 shares of the company traded hands, compared to its average volume of 7,948,531. The stock has a fifty day moving average price of $154.63 and a 200-day moving average price of $153.64. The stock has a market cap of $369.19 billion, a price-to-earnings ratio of 23.07, a price-to-earnings-growth ratio of 2.56 and a beta of 0.42. Johnson & Johnson has a one year low of $140.68 and a one year high of $169.99. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.86 and a current ratio of 1.11.

Johnson & Johnson (NYSE:JNJ - Get Free Report) last released its earnings results on Tuesday, April 15th. The company reported $2.77 EPS for the quarter, beating analysts' consensus estimates of $2.59 by $0.18. Johnson & Johnson had a return on equity of 34.24% and a net margin of 18.20%. The business had revenue of $21.89 billion for the quarter, compared to analysts' expectations of $21.65 billion. On average, equities analysts predict that Johnson & Johnson will post 10.58 earnings per share for the current fiscal year.

Johnson & Johnson Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 10th. Stockholders of record on Tuesday, May 27th will be issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 3.39%. This is a positive change from Johnson & Johnson's previous quarterly dividend of $1.24. The ex-dividend date of this dividend is Tuesday, May 27th. Johnson & Johnson's payout ratio is presently 57.84%.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.